Cash Flow for Infinity Pharmaceuticals, Inc. (INFI)

Cash Flow for Infinity Pharmaceuticals, Inc.
Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Net Income
Net Income -126,780,000 -53,964,000 -40,042,000
Operating Activities, Cash Flows Provided By or Used In
Depreciation 4,024,000 3,296,000 4,602,000
Adjustments To Net Income 12,568,000 9,926,000 5,615,000
Changes In Accounts Receivables - 218,000 -218,000
Changes In Liabilities 3,565,000 -38,574,000 -3,422,000
Changes In Inventories - - -
Changes In Other Operating Activities -7,284,000 -1,037,000 356,000
Total Cash Flow From Operating Activities -113,907,000 -80,135,000 -33,109,000
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures -1,754,000 -1,301,000 -1,542,000
Investments 2,360,000 -60,697,000 -12,146,000
Other Cash flows from Investing Activities - - -
Total Cash Flows From Investing Activities 606,000 -61,998,000 -13,688,000
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid - - -
Sale Purchase of Stock 5,673,000 293,678,000 582,000
Net Borrowings - - 50,000,000
Other Cash Flows from Financing Activities - - -5,000
Total Cash Flows From Financing Activities 5,673,000 293,678,000 50,577,000
Effect Of Exchange Rate Changes - - -
Change In Cash and Cash Equivalents -107,628,000 151,545,000 3,780,000